Infinitopes Precision Immunomics
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$70.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Infinitopes Precision Immunomics is a biotechnology company that develops precision cancer vaccines using its proprietary antigen discovery platform and viral vector delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinitopes Precision Immunomics Comparables
Compare Infinitopes Precision Immunomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| myNEO Therapeutics | 83% | |
| Epitopea | 79% | |
| Nouscom | 79% |
Infinitopes Precision Immunomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2026 | ||||
| Seed | Apr 30, 2024 |
Key People
Founding team and executive leadership
Infinitopes Precision Immunomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| Cancer Research Horizons | Seed |
| Saras Capital | Seed |
| Meltwind Advisory | Seed |
| Kindred Capital | Seed |
| Amplify Partners | Seed |
| Manta Ray Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
$35.1M raised in Seed funding.
- Mar 20, 2025
Jo Brewer appointed as Non-Executive Director
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
Infinitopes is developing new generation of off-the-shelf precision cancer vaccines on Sep 9th '26.
- is_developingAug 6, 2026
Infinitopes is developing ITOP1.
- hiresJul 28, 2026
Infinitopes hired Kristen Hege as Scientific Advisory Board member on Jul 28th '26.
Infinitopes Precision Immunomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Infinitopes Precision Immunomics's valuation, stock price, and market status.
Is Infinitopes Precision Immunomics a public or private company?
Infinitopes Precision Immunomics is a private company.
What is the current stock price of Infinitopes Precision Immunomics?
Infinitopes Precision Immunomics is a private company with no public stock price. No recent secondary market data is available.
How much is Infinitopes Precision Immunomics worth (valuation)?
Valuation information for Infinitopes Precision Immunomics is not publicly available.
Can I buy Infinitopes Precision Immunomics stock?
Infinitopes Precision Immunomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Infinitopes Precision Immunomics's last funding round?
Infinitopes Precision Immunomics's most recent funding round was Seed on January 21, 2026.
Who are the main investors in Infinitopes Precision Immunomics?
Key investors in Infinitopes Precision Immunomics include Octopus Ventures.
Will Infinitopes Precision Immunomics IPO soon?
No public IPO plans have been announced for Infinitopes Precision Immunomics.
How can I track Infinitopes Precision Immunomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Infinitopes Precision Immunomics's secondary market activity and sign up for updates.